Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abbott Korea is the South Korean subsidiary of the global healthcare leader Abbott Laboratories, providing a diverse portfolio of products across diagnostics, medical devices, nutrition, and established pharmaceuticals. The company is a market leader in Korea for continuous glucose monitoring with its FreeStyle Libre system and offers a wide range of cardiovascular solutions, including coronary stents and structural heart devices. Additionally, Abbott Korea supplies essential nutritional products like Ensure and high-tech diagnostic equipment used in hospitals and laboratories nationwide. Its business model focuses on localizing global innovations to meet the specific needs of the South Korean healthcare system and its patients. The company operates through multiple divisions to improve patient outcomes across various stages of care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abbott Korea.